Paydirt
MA
Insider

Maricel Apuli

Chief Accounting Officer

Maricel Apuli (Chief Accounting Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $160K of BBIO (2,000 sh × $80.06, as filed), executed Jul 30.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
4
0 buys · 4 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$584K
shares × price, as filed
Last traded
Jul 30
Filed Aug 3

Median ADV $293.8M across their filed names

Open performance
Volume by month
$160K$80K$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · sells $149KFeb 2026 · sells $132KMay 2026 · sells $143KAug 2026 · sells $160K
Buys $0 Sells $584K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names
BBIO BridgeBio Pharma, Inc. BBIO · 0 buys · 4 sells 4 filings
Recent filings
BBIOSALE BridgeBio Pharma, Inc. View filing → $160K
2,000 sh × $80.06
Exec Jul 30
Filed Aug 3 · 4:20 PM ET
BBIOSALE BridgeBio Pharma, Inc. View filing → $143K
2,000 sh × $71.58
Exec Apr 30
Filed May 4 · 5:30 PM ET
BBIOSALE BridgeBio Pharma, Inc. View filing → $132K
2,000 sh × $66.00
Exec Feb 26
Filed Feb 27 · 5:30 PM ET
BBIOSALE BridgeBio Pharma, Inc. View filing → $149K
2,000 sh × $74.26
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET